173 related articles for article (PubMed ID: 11316253)
1. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
[No Abstract] [Full Text] [Related]
2. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
Reuter SE; Faull RJ; Ranieri E; Evans AM
Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
[TBL] [Abstract][Full Text] [Related]
3. An unusual etiology of erythropoietin resistance: hyperthyroidism.
Kaynar K; Ozkan G; Erem C; Gul S; Yilmaz M; Sonmez B; Ozdemir F; Ulusoy S
Ren Fail; 2007; 29(6):759-61. PubMed ID: 17763175
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin resistance in the treatment of the anemia of chronic renal failure.
Priyadarshi A; Shapiro JI
Semin Dial; 2006; 19(4):273-8. PubMed ID: 16893403
[TBL] [Abstract][Full Text] [Related]
5. [Hyporesponsiveness to recombinant human erythropoietin therapy in anemic patients on hemodialysis].
Maeda H; Hirakata H
Nihon Rinsho; 2004 Jun; 62 Suppl 6():307-11. PubMed ID: 15250314
[No Abstract] [Full Text] [Related]
6. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.
Costa E; Swinkels DW; Laarakkers CM; Rocha-Pereira P; Rocha S; Reis F; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Acta Haematol; 2009; 122(4):226-9. PubMed ID: 19887781
[No Abstract] [Full Text] [Related]
8. Erythropoietin and its use in renal failure.
Sulková S; Krajhanzl A
EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
[TBL] [Abstract][Full Text] [Related]
9. [Anemia in chronic renal failure and erythropoietin].
Rosenlöf K
Duodecim; 1995; 111(15):1489-95. PubMed ID: 9244705
[No Abstract] [Full Text] [Related]
10. Anemia in renal insufficiency.
Santoro A
Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
[TBL] [Abstract][Full Text] [Related]
11. Target hemoglobin level for EPO therapy in CKD.
Parfrey PS
Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
[No Abstract] [Full Text] [Related]
12. The role of oral L-carnitine therapy in chronic hemodialysis patients.
Sabry AA
Saudi J Kidney Dis Transpl; 2010 May; 21(3):454-9. PubMed ID: 20427868
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic guidelines for renal anemia in Japan].
Naito M; Akiba T
Nihon Rinsho; 2004 Jun; 62 Suppl 6():562-5. PubMed ID: 15250369
[No Abstract] [Full Text] [Related]
14. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
15. Pure red cell aplasia followed by disseminated intravascular coagulation in a haemodialysis patient receiving erythropoietin-beta.
Manenti L; Vaglio A
Nephrol Dial Transplant; 2007 May; 22(5):1465-7. PubMed ID: 17337465
[No Abstract] [Full Text] [Related]
16. [Case of early pronounced anemia and its effective treatment with human recombinant erythropoietin in a female patient with polycystic kidney in a conservative stage of chronic renal failure].
Alekseeva TB; Nikolaev AIu; Trofimova EI
Ter Arkh; 1999; 71(6):70-1. PubMed ID: 10420463
[No Abstract] [Full Text] [Related]
17. Continuous quality improvement (CQI) in rhu-Epo management: the outcome.
Descamps C; Van Waeleghem JP; Ysebaert D
EDTNA ERCA J; 1996; 22(3):22-6. PubMed ID: 10723328
[TBL] [Abstract][Full Text] [Related]
18. The EPO/iron marriage: counseling needed.
Bralow S
Nephrol News Issues; 2007 Jun; 21(7):53, 55. PubMed ID: 17623987
[No Abstract] [Full Text] [Related]
19. Hypothyroidism and resistance to human recombinant erythropoietin.
Touam M; Guéry B; Goupy C; Menoyo V; Drüeke T
Nephrol Dial Transplant; 2004 Apr; 19(4):1020-1. PubMed ID: 15031379
[No Abstract] [Full Text] [Related]
20. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
